156 related articles for article (PubMed ID: 32184594)
1. Folate-Mediated Targeted Delivery of siPLK1 by Leucine-Bearing Polyethylenimine.
Hou L; Song Z; Xu Z; Wu Y; Shi W
Int J Nanomedicine; 2020; 15():1397-1408. PubMed ID: 32184594
[TBL] [Abstract][Full Text] [Related]
2. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
[TBL] [Abstract][Full Text] [Related]
3. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
4. Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics.
Wang Z; Zhao S; Shi J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2022 Jan; 138():443-452. PubMed ID: 34757229
[TBL] [Abstract][Full Text] [Related]
5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
6. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.
Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J
Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
[TBL] [Abstract][Full Text] [Related]
8. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
[TBL] [Abstract][Full Text] [Related]
9. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
Mok WC; Wasser S; Tan T; Lim SG
World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery.
Shi M; Zhao X; Zhang J; Pan S; Yang C; Wei Y; Hu H; Qiao M; Chen D; Zhao X
Int J Nanomedicine; 2018; 13():6885-6902. PubMed ID: 30498349
[TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of polo like kinase gene expression induces apoptosis in gastric cancer cells].
Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):62-6. PubMed ID: 16437376
[TBL] [Abstract][Full Text] [Related]
14. Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.
Li J; Liu J; Li S; Hao Y; Chen L; Zhang X
Oncotarget; 2016 Mar; 7(12):13782-96. PubMed ID: 26883109
[TBL] [Abstract][Full Text] [Related]
15. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.
Gerster K; Shi W; Ng B; Yue S; Ito E; Waldron J; Gilbert R; Liu FF
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):253-60. PubMed ID: 20394857
[TBL] [Abstract][Full Text] [Related]
16. PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
Reda M; Ngamcherdtrakul W; Gu S; Bejan DS; Siriwon N; Gray JW; Yantasee W
Cancer Lett; 2019 Dec; 467():9-18. PubMed ID: 31563561
[TBL] [Abstract][Full Text] [Related]
17. Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.
Xing Z; Gao S; Duan Y; Han H; Li L; Yang Y; Li Q
Int J Nanomedicine; 2015; 10():5715-27. PubMed ID: 26425080
[TBL] [Abstract][Full Text] [Related]
18. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.
Liu DZ; Cheng Y; Cai RQ; Wang Bd WW; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine; 2018 Apr; 14(3):991-1003. PubMed ID: 29339188
[TBL] [Abstract][Full Text] [Related]
19. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
